Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Toronto
$27,000.00
Assessing the Validity of Self-reported Age-related Macular Degeneration and Glaucoma: Evidence from a Canadian Population-based Study
EF 2025-26
Résumé
Age-related macular degeneration (AMD) and glaucoma are the leading causes of irreversible blindness in Canada and globally. Knowing the number of Canadians affected by AMD and glaucoma is essential for understanding how common these eye diseases are, who is most at risk, and which factors might increase or decrease the risk. While such data is available from many countries, data from Canada is limited. This is mainly because diagnosing AMD and glaucoma requires eye exams with sophisticated equipment and professional interpretation, which is a costly undertaking on a large population-based sample. Self-reported surveys offer a practical, low-cost option to study AMD and glaucoma, but they are vulnerable to biases, e.g., forgetting a diagnosis, misunderstanding medical terms, or worrying that reporting having AMD or glaucoma might lead to the loss of a driver’s license. To date, no study has evaluated how accurate these self-reports are for Canadians.
We will address this gap by evaluating the accuracy of self-reports of AMD and glaucoma compared to eye exam-based diagnoses from the Canadian Health Measures Survey (CHMS), which serves as the gold standard. The CHMS, conducted between 2016-2019, is the only national source that includes both self-reported and eye-exam data on AMD and glaucoma from Canadians. We will also estimate of the number of Canadians living with AMD.
This will be the first Canadian study to assess the accuracy and usefulness of self-reported AMD and glaucoma compared to eye-exam results. Study findings will add important new knowledge to vision research in Canada and worldwide. In addition, this study will provide the first data on AMD prevalence, aiding Canadian health resource planning and vision policy research.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
573102
Name
Rizza Stephanie A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Assessing the Validity of Self-reported Age-related Macular Degeneration and Glaucoma: Evidence from a Canadian Population-based Study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Age-Related Macular Degeneration; Epidemiology; Glaucoma; Population Health; Prevalence; Self-Report; Sensitivity; Specificity; Survey; Validity
Abstract
Age-related macular degeneration (AMD) and glaucoma are the leading causes of irreversible blindness in Canada and globally. Knowing the number of Canadians affected by AMD and glaucoma is essential for understanding how common these eye diseases are, who is most at risk, and which factors might increase or decrease the risk. While such data is available from many countries, data from Canada is limited. This is mainly because diagnosing AMD and glaucoma requires eye exams with sophisticated equipment and professional interpretation, which is a costly undertaking on a large population-based sample. Self-reported surveys offer a practical, low-cost option to study AMD and glaucoma, but they are vulnerable to biases, e.g., forgetting a diagnosis, misunderstanding medical terms, or worrying that reporting having AMD or glaucoma might lead to the loss of a driver’s license. To date, no study has evaluated how accurate these self-reports are for Canadians.
We will address this gap by evaluating the accuracy of self-reports of AMD and glaucoma compared to eye exam-based diagnoses from the Canadian Health Measures Survey (CHMS), which serves as the gold standard. The CHMS, conducted between 2016-2019, is the only national source that includes both self-reported and eye-exam data on AMD and glaucoma from Canadians. We will also estimate of the number of Canadians living with AMD.
This will be the first Canadian study to assess the accuracy and usefulness of self-reported AMD and glaucoma compared to eye-exam results. Study findings will add important new knowledge to vision research in Canada and worldwide. In addition, this study will provide the first data on AMD prevalence, aiding Canadian health resource planning and vision policy research.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rizza, Stephanie A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~